Startseite Detection of Hpdel in healthy individuals and cancer patients in Taiwan
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Detection of Hpdel in healthy individuals and cancer patients in Taiwan

  • Yu-Chieh Su , Yi-Chun Chen , Szu-Chin Li , Ching-Chih Lee und Ya-Ting Tung
Veröffentlicht/Copyright: 30. April 2009
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: We investigated the genotypic distribution of Hpdel in healthy subjects and cancer patients in Taiwan.

Methods: Blood samples were collected from 244 randomly selected healthy Taiwanese volunteers and 737 patients with various cancers. Samples were analyzed for the haptoglobin (Hp) gene, and the presence of the Hpdel allele was determined from genomic DNA by an Hpdel-specific polymerase chain reaction (PCR) method. The plasma concentration of Hp was also determined.

Results: The frequency of the Hpdel allele was calculated to be 0.029, and was not different between the healthy subjects and patients with cancer. The prevalence of Hp deficiency caused by Hpdel homozygosity was estimated to be ∼0.85 in 1000. Fifty-seven subjects were reclassified from homozygous Hp1 or Hp2 to Hp1/Hpdel or Hp2/Hpdel genotypes. The Hpdel allele is not associated with prevalence, severity or stage of any cancer.

Conclusions: Congenital Hp deficiency caused by Hpdel homozygosity is a condition present in Taiwan with a relatively high frequency. However, the Hpdel variant does not play a role in cancer.

Clin Chem Lab Med 2009;47:745–9.


Corresponding author: Dr. Yu-Chieh Su, Division of Hematology-Oncology, Department of Internal Medicine, Buddhist Tzu Chi Dalin General Hospital, No. 2, Min Sheng Road, Dalin Town, Chiayi County, Taiwan, Republic of China Phone: +886-5-2648000-5665, Fax: +886-5-2648128,

Received: 2009-1-16
Accepted: 2009-3-24
Published Online: 2009-04-30
Published in Print: 2009-06-01

©2009 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editorial
  2. A focus on recent advances in proteomics – one step closer to entrance into the clinical arena
  3. Reviews
  4. Proteomics in protein misfolding diseases
  5. Multidimensional protein identification technology for clinical proteomic analysis
  6. Technical advances in proteomics mass spectrometry: identification of post-translational modifications
  7. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective
  8. Research Papers
  9. Thrombin induces broad spectrum proteolysis in human serum samples
  10. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS)
  11. Proteomics of exhaled breath: methodological nuances and pitfalls
  12. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry
  13. Approaching clinical proteomics: current state and future fields of application in fluid proteomics
  14. Genetics and Molecular Diagnostics
  15. Detection of Hpdel in healthy individuals and cancer patients in Taiwan
  16. Increased CA 19-9 level in patients without malignant disease
  17. General Clinical Chemistry and Laboratory Medicine
  18. Quantitation of cerebrospinal fluid lactic acid in infectious and non-infectious neurological diseases
  19. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study
  20. Reference Values and Biological Variations
  21. Influence of tourniquet application on venous blood sampling for serum chemistry, hematological parameters, leukocyte activation and erythrocyte mechanical properties
  22. Systemic cytokine response following exercise-induced muscle damage in humans
  23. Letters to the Editor
  24. CACNA1A gene non-synonymous single nucleotide polymorphisms and common migraine in Italy: a case-control association study with a micro-array technology
  25. Proficiency test of plasma free and total metanephrines: report from a study group
Heruntergeladen am 6.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.156/pdf
Button zum nach oben scrollen